When performing whole genome sequencing, clinicians may encounter incidental findings unrelated to the condition for which the patient was tested. The American College of Medical Genetics and Genomics recently recommended that clinical labs should be required to analyze 56 genes that increase the likelihood of diseases for which there is an intervention.